TheStreet

Shares of Endo International (ENDP - Get Report) rocketed Tuesday on news of its $10 million settlement with a pair of Ohio counties suing drugmakers over their alleged roles in fueling the opioid epidemic in the United States.

Endo's stock price surged 28.86% to $3.23 after the company announced the settlement with Cuyahoga and Summit counties, removing the company from a potentially damaging trial in October.

The "settlement in principle" includes Endo's pledge to provide up to "$1 million of its Vasostrict and Adrenalin products free of charge," the company said in a statement.

Fellow opioid maker Allergan (AGN - Get Report) is said to be discussing paying $5 million to settle the claims pushed by the Ohio counties, The Wall Street Journal has reported.

The amounts said to be discussed for Allergan and Endo to settle (or partially settle) are far lower than those other companies already have paid. For instance, Purdue Pharma paid $270 million, and Teva Pharmaceutical Industries  (TEVA - Get Report)  stumped up $85 million to deal with claims in Oklahoma.

Save 57% With Our Labor Day Sale. Join Jim Cramer's Action Alerts PLUS investment club to become a smarter investor! Click here to sign up!